Asia Pacific Neuralgia Treatment Market Size & Outlook

The neuralgia treatment market in Asia Pacific is expected to reach a projected revenue of US$ 658.8 million by 2030. A compound annual growth rate of 7.4% is expected of Asia Pacific neuralgia treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$431.4
Forecast, 2030 (US$M)
$658.8
CAGR, 2025 - 2030
7.4%
Report Coverage
Asia Pacific

Asia Pacific neuralgia treatment market, 2018-2030 (US$M)

Asia

Asia Pacific neuralgia treatment market highlights

  • The Asia Pacific neuralgia treatment market generated a revenue of USD 431.4 million in 2024.
  • The market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
  • In terms of segment, surgery was the largest revenue generating treatment in 2024.
  • Drug Based is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 431.4 million
Market revenue in 2030USD 658.8 million
Growth rate7.4% (CAGR from 2025 to 2030)
Largest segmentSurgery
Fastest growing segmentDrug Based
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Based, Surgery
Key market players worldwideGlaxoSmithKline Consumer Healthcare (GSK CH India), GlaxoSmithKline, Pfizer Inc, Novartis AG ADR, Biogen Inc, H. Lundbeck AS Class A, Cadila Pharmaceuticals

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 18.4% of the global neuralgia treatment market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 658.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neuralgia Treatment Market Companies

Name Profile # Employees HQ Website

Asia Pacific neuralgia treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuralgia treatment market will help companies and investors design strategic landscapes.


Surgery was the largest segment with a revenue share of 69.12% in 2024. Horizon Databook has segmented the Asia Pacific neuralgia treatment market based on drug based, surgery covering the revenue growth of each sub-segment from 2018 to 2030.


  • Asia Pacific Neuralgia Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
    • Drug Based
      • Anticonvulsant Medicines
      • Tricyclic Antidepressants
    • Surgery
      • Radiofrequency Thermal Lesioning
      • Stereotactic Radiosurgery
      • Microvascular Decompression
      • Others
  • Asia Pacific Neuralgia Treatment End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospital & Clinics
    • Ambulatory Surgery Centers
    • Others

Reasons to subscribe to Asia Pacific neuralgia treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific neuralgia treatment market databook

  • Our clientele includes a mix of neuralgia treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific neuralgia treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific neuralgia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific neuralgia treatment market size, by country, 2018-2030 (US$M)

Asia Pacific Neuralgia Treatment Market Share, 2024 & 2030 (US$M)

Asia Pacific neuralgia treatment market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more